DAVID
ANDALUZ OJEDA
Investigador en el periodo 2020-2020
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)
2022
-
ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points
Frontiers in Medicine, Vol. 9
-
Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study
International Journal of Molecular Sciences, Vol. 23, Núm. 23
2020
-
MR- proADM to detect specific types of organ failure in infection
European Journal of Clinical Investigation, Vol. 50, Núm. 6